WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
21 Bridge Street
Metuchen, NJ 08840, USA
Tel/Fax: +1 801-751-5728
info@pharmachinaonline.com

Affiliated Companies
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

BJ Jicai PharmTech
Oriental Kenzo Plaza
Beijing, China
Tel: +86 10 84476010
info@pharmachinaonline.com

China Appears to Open Wider to Innovative Medicines as It Intensify Healthcare... Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with emphasis on IP strategies for MNCs in China, various new healthcare cost containme...
(12/31/2020)

Top JPMorgan Banker Sees Steady Supply of Chin... (1/18/2021)

Novartis, Once Wary of Chinese M&A, Dives into... (1/14/2021)

Pharma Companies to Cut Prices of News Drugs b... (1/14/2021)

What Do Novartis Deal, PD-1 Competition In Chi... (1/14/2021)

Reform Has Unleashed Chinese Drugs Innovation ... (1/14/2021)

S&P Global: China's Big Tech to Continue Disru... (1/8/2021)

SMCP - Coronavirus in China: 2021 Outlook Brig... (1/8/2021)

Economic Burden and Health Care Access for Pat... (1/7/2021)

China Appears to Open Wider to Innovative Medi... (12/31/2020)

Merck, Bristol Myers, AstraZeneca and Roche Lo... (12/29/2020)

NMPA Revises Packages Inserts of Pamidro... (1/19/2021) NMPA Announces OTC Switch of Budesonide ... (1/19/2021) Everest Medicines Announces Amended Agre... (1/19/2021) TenNor Enters Research Collaboration wit... (1/19/2021) Innovent Announces an Out-license Deal w... (1/19/2021) (Free) USTR Unleashes 2020 Report for China's W... (1/18/2021) Teva Launches Huntington's Drug Austedo ... (1/18/2021) CDE Issues the Technical Guidelines for ... (1/18/2021) Kyowa Kirin Granted Conditional Approval... (1/18/2021) Recent Executive Moves (1/15/2021) JPO Issues Bidding Documents for the Fou... (1/15/2021) CDE Issues the Technical Guidelines for ... (1/15/2021) Innovent's sNDA for Sintilimab as Second... (1/15/2021) CDE Issues the Technical Guidelines for ... (1/15/2021) China Officially Bans Phenolphthalein Ta... (1/14/2021) (Free) EOC Pharma Licenses Aadi Bioscience's mT... (1/14/2021) Chiome and Henlius Sign Greater China Li... (1/14/2021) NHSA Highlights Ten Major Tasks in 2021 (1/14/2021)

Domestic PD-1s in the 2020 NRDL Negotiated Entry: Winne... China to Lower Import Tariffs on 883 Products with Zero... Review and Forecast of Chinese Antiviral Drug Market 20... Global and China CRO Industry Report, 2020-2026 – M&As... CPA Hospital Drug Consumption Audit Reveals Elevated Co...

Innovent Announces an Out-license Deal with PT Etana to... TenNor Enters Research Collaboration with Janssen for P... Everest Medicines Announces Amended Agreement with Sper... Teva Launches Huntington's Drug Austedo in China Chiome and Henlius Sign Greater China Licensing Deal fo...

NMPA Announces OTC Switch of Budesonide Nasal Spray NMPA Revises Packages Inserts of Pamidronate Disodium I... CDE Issues the Technical Guidelines for Clinical Trial ... CDE Issues the Technical Guidelines for Quality Studies... CDE Issues the Technical Guidelines for Image Evaluatio...

JPO Issues Bidding Documents for the Fourth Batch of VB... NHSA Highlights Ten Major Tasks in 2021 Swiss Re Sees Short-term Health insurance as Growth Dri... NHSA Issues Two Interim Rules for Management of BMI Des... NHC Issues Two New Documents on Public Hospital Managem...

USTR Unleashes 2020 Report for China's WTO Compliance H... China Ups Drug Regulation, Biosecurity and IPR Protecti... China's New Export Control Law Triggers More Trade and ... Genscript Chairman Arrested on Suspected Smuggling Offe... Wanbangde Pharma Fined CNY 2.5M for Abuse of Market Mon...

India Probes Alleged API Dumping by Chinese Companies China Increases Prices of Key Drug Ingredients by Up To... U.S. Introduces A 'Buy American First' Pharma Executive... Fitch: No Near-Term Impact on Chinese API Makers as Pha... Indian Firms Challenged by API Price Hikes by Chinese S...

Kyowa Kirin Granted Conditional Approval of Crysvita (b... Innovent's sNDA for Sintilimab as Second-line Therapy f... Sesen Bio and Qilu Pharma Announce Acceptance IND for ... Gracell Approved to Begin Phase 1/2 Trial of CAR-T GC0... VISEN Pharma Granted IND Approval for P2 Trial of Acho...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

Upcoming Event: Plenareno Pharma Middle East Virtual Co... Live Podcast - VC & Impact Investing in China: Investin... 2020 Fall/Winter Promotion - Pharma China publications USTR Satisfied with China's Implementatin of Phase 1 US... U.S.-China ESRC Hearing: China's Evolving Healthcare Sy...

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

Pharma China on Twitter and Faceboo... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON to Hold Pharma China Annual F... WiCON Publishes the China Pharmaceu...